Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 14:27:18 2024-07-17 EDT			5-day change	1st Jan Change
121.3 ^USD	-3.14%		+7.00%	-13.03%

07-10	Nvidia leads Nasdaq and S&P 500 to record highs	RE
07-10	Sector Update: Health Care Stocks Steady Premarket Wednesday	MT

Illumina Inc. acquired Moleculo, Inc. from Mickey Kertesz, Dmitry Pushkarev, Data Collective and Life Science Angels, Inc.

January 07, 2013 at 11:00 pm

Illumina Inc. (NasdaqGS:ILMN) acquired Moleculo, Inc. from Mickey Kertesz, Dmitry Pushkarev, Data Collective and Life Science Angels, Inc. in December 2012.

Illumina Inc. (NasdaqGS:ILMN) completed the acquisition of Moleculo, Inc. from Mickey Kertesz, Dmitry Pushkarev, Data Collective and Life Science Angels, Inc. in December 2012.

Latest news about Illumina, Inc.

Nvidia leads Nasdaq and S&P 500 to record highs	07-10	RE
Sector Update: Health Care Stocks Steady Premarket Wednesday	07-10	MT
Sector Update: Health Care	07-10	MT
Megacaps boost futures as Wall Street stays upbeat ahead of data, earnings	07-10	RE
Citigroup Upgrades Illumina to Buy From Neutral, Price Target is $140	07-10	MT
Illumina Acquires Fluent BioSciences, Expanding Multiomics Strategy	07-09	MT
Illumina, Inc. acquired Fluent BioSciences Inc.	07-08	CI
RBC Lowers Price Target on Illumina to $242 From $249, Keeps Outperform Rating	07-01	MT
ANALYST RECOMMENDATIONS : Nvidia, Broadcom, Progressive, Draftkings, Moody's...	07-01
Illumina, Inc.(NasdaqGS:ILMN) dropped from Russell 3000E Growth Index	06-30	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from Russell 1000 Growth Index	06-30	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from Russell Midcap Growth Index	06-30	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from Russell 3000 Growth Index	06-30	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from Russell Small Cap Comp Growth Index	06-30	CI
Would you like some more inflation?	06-28
Illumina to Record $1.47 Goodwill Impairment Charge in Q2 After Grail Spin-Off	06-28	MT
Illumina to take $1.47 billion impairment charge related to Grail in Q2	06-27	RE
Illumina Completes Grail Spin-Off Into Publicly Traded Entity, Holds Minority Stake	06-24	MT
Grail bets big on flagship cancer test after spin-off from Illumina	06-24	RE
Illumina, Inc. completed the Spin-Off of GRAIL, LLC.	06-23	CI
Illumina, Inc.(NasdaqGS:ILMN) added to S&P 1000	06-23	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from S&P 500 Equal Weighted	06-23	CI
Illumina, Inc.(NasdaqGS:ILMN) added to S&P 400 Health Care	06-23	CI
Illumina, Inc.(NasdaqGS:ILMN) dropped from S&P 500 Value	06-23	CI
Illumina, Inc.(NasdaqGS:ILMN) added to S&P 400	06-23	CI

Chart Illumina, Inc.

Duration

Period

More charts

Company Profile

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (15.9%). Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-06 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Illumina, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

125.2 USD

Average target price

147.2 USD

Spread / Average Target

+17.58%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ILLUMINA, INC.	-13.03%	19.94B
THERMO FISHER SCIENTIFIC	+4.75%	212B
DANAHER CORPORATION	+8.92%	187B
INTUITIVE SURGICAL, INC.	+27.91%	155B
BOSTON SCIENTIFIC CORPORATION	+34.15%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.16%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
AGILENT TECHNOLOGIES, INC.	-3.57%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.31%	37.72B

Other Advanced Medical Equipment & Technology